Biotech Values

[DonShimoda]

Clearly, non-squamous did not capture the high c-Met that the trial was hoping for. Thanks to the discussions on this board, i kept my exposure relatively small. It's disappointing to be statsig on PFS and yet have the trial stopped for futility.

***Note to self - try to avoid investing in a p3 trial without a confirmed P2 target and the same endpoint! (a lesson I should have learned with ridaforolimus, lol)